vs

Side-by-side financial comparison of HEARTLAND EXPRESS INC (HTLD) and Immunocore Holdings plc (IMCR). Click either name above to swap in a different company.

HEARTLAND EXPRESS INC is the larger business by last-quarter revenue ($179.4M vs $104.5M, roughly 1.7× Immunocore Holdings plc). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs -26.1%). Immunocore Holdings plc produced more free cash flow last quarter ($-35.5M vs $-44.2M). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs -18.5%).

Heartland Express is an American trucking company headquartered in North Liberty, Iowa. The company offers truckload shipping services across the United States.

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

HTLD vs IMCR — Head-to-Head

Bigger by revenue
HTLD
HTLD
1.7× larger
HTLD
$179.4M
$104.5M
IMCR
Growing faster (revenue YoY)
IMCR
IMCR
+50.4% gap
IMCR
24.3%
-26.1%
HTLD
More free cash flow
IMCR
IMCR
$8.7M more FCF
IMCR
$-35.5M
$-44.2M
HTLD
Faster 2-yr revenue CAGR
IMCR
IMCR
Annualised
IMCR
21.7%
-18.5%
HTLD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HTLD
HTLD
IMCR
IMCR
Revenue
$179.4M
$104.5M
Net Profit
$-19.4M
Gross Margin
97.4%
Operating Margin
-12.7%
-18.8%
Net Margin
-10.8%
Revenue YoY
-26.1%
24.3%
Net Profit YoY
-949.2%
EPS (diluted)
$-0.24
$-0.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HTLD
HTLD
IMCR
IMCR
Q4 25
$179.4M
$104.5M
Q3 25
$196.5M
$103.7M
Q2 25
$210.4M
$98.0M
Q1 25
$219.4M
$93.9M
Q4 24
$242.6M
$84.1M
Q3 24
$259.9M
$80.2M
Q2 24
$274.8M
$75.4M
Q1 24
$270.3M
$70.5M
Net Profit
HTLD
HTLD
IMCR
IMCR
Q4 25
$-19.4M
Q3 25
$-8.3M
$-177.0K
Q2 25
$-10.9M
$-10.3M
Q1 25
$-13.9M
$5.0M
Q4 24
$-1.9M
Q3 24
$-9.3M
$8.7M
Q2 24
$-3.5M
$-11.6M
Q1 24
$-15.1M
$-24.4M
Gross Margin
HTLD
HTLD
IMCR
IMCR
Q4 25
97.4%
Q3 25
99.5%
Q2 25
98.9%
Q1 25
99.1%
Q4 24
99.6%
Q3 24
99.4%
Q2 24
97.7%
Q1 24
99.7%
Operating Margin
HTLD
HTLD
IMCR
IMCR
Q4 25
-12.7%
-18.8%
Q3 25
-3.7%
-6.9%
Q2 25
-5.9%
-15.2%
Q1 25
-6.8%
-3.9%
Q4 24
0.4%
-23.1%
Q3 24
-2.7%
-10.6%
Q2 24
0.1%
-21.2%
Q1 24
-5.3%
-37.6%
Net Margin
HTLD
HTLD
IMCR
IMCR
Q4 25
-10.8%
Q3 25
-4.2%
-0.2%
Q2 25
-5.2%
-10.5%
Q1 25
-6.3%
5.4%
Q4 24
-0.8%
Q3 24
-3.6%
10.9%
Q2 24
-1.3%
-15.4%
Q1 24
-5.6%
-34.7%
EPS (diluted)
HTLD
HTLD
IMCR
IMCR
Q4 25
$-0.24
$-0.61
Q3 25
$-0.11
$0.00
Q2 25
$-0.14
$-0.20
Q1 25
$-0.18
$0.10
Q4 24
$-0.03
$-0.47
Q3 24
$-0.12
$0.17
Q2 24
$-0.04
$-0.23
Q1 24
$-0.19
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HTLD
HTLD
IMCR
IMCR
Cash + ST InvestmentsLiquidity on hand
$18.5M
$864.2M
Total DebtLower is stronger
$154.1M
Stockholders' EquityBook value
$755.3M
$381.0M
Total Assets
$1.2B
$1.1B
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HTLD
HTLD
IMCR
IMCR
Q4 25
$18.5M
$864.2M
Q3 25
$32.7M
$892.4M
Q2 25
$22.9M
$882.8M
Q1 25
$23.9M
$837.0M
Q4 24
$12.8M
$820.4M
Q3 24
$30.7M
$901.3M
Q2 24
$23.9M
$859.6M
Q1 24
$23.8M
$832.8M
Total Debt
HTLD
HTLD
IMCR
IMCR
Q4 25
$154.1M
Q3 25
Q2 25
Q1 25
Q4 24
$187.9M
Q3 24
$438.7M
Q2 24
$452.5M
Q1 24
$452.5M
Stockholders' Equity
HTLD
HTLD
IMCR
IMCR
Q4 25
$755.3M
$381.0M
Q3 25
$775.6M
$396.6M
Q2 25
$786.7M
$388.5M
Q1 25
$807.7M
$378.5M
Q4 24
$822.6M
$360.7M
Q3 24
$825.7M
$377.8M
Q2 24
$836.8M
$359.1M
Q1 24
$848.8M
$359.5M
Total Assets
HTLD
HTLD
IMCR
IMCR
Q4 25
$1.2B
$1.1B
Q3 25
$1.3B
$1.1B
Q2 25
$1.3B
$1.1B
Q1 25
$1.3B
$1.0B
Q4 24
$1.3B
$1.0B
Q3 24
$1.4B
$1.1B
Q2 24
$1.4B
$1.0B
Q1 24
$1.5B
$994.0M
Debt / Equity
HTLD
HTLD
IMCR
IMCR
Q4 25
0.20×
Q3 25
Q2 25
Q1 25
Q4 24
0.23×
Q3 24
1.16×
Q2 24
1.26×
Q1 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HTLD
HTLD
IMCR
IMCR
Operating Cash FlowLast quarter
$14.9M
$-32.7M
Free Cash FlowOCF − Capex
$-44.2M
$-35.5M
FCF MarginFCF / Revenue
-24.6%
-34.0%
Capex IntensityCapex / Revenue
33.0%
2.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-66.9M
$-15.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HTLD
HTLD
IMCR
IMCR
Q4 25
$14.9M
$-32.7M
Q3 25
$27.5M
$-4.5M
Q2 25
$21.0M
$26.0M
Q1 25
$25.8M
$435.0K
Q4 24
$37.8M
$-14.0M
Q3 24
$35.6M
$21.1M
Q2 24
$40.0M
$23.5M
Q1 24
$31.0M
$-4.6M
Free Cash Flow
HTLD
HTLD
IMCR
IMCR
Q4 25
$-44.2M
$-35.5M
Q3 25
$-12.2M
$-5.2M
Q2 25
$-12.8M
$25.6M
Q1 25
$2.3M
$137.0K
Q4 24
$-45.5M
$-17.5M
Q3 24
$24.6M
$20.3M
Q2 24
$29.4M
$23.1M
Q1 24
$26.3M
$-5.0M
FCF Margin
HTLD
HTLD
IMCR
IMCR
Q4 25
-24.6%
-34.0%
Q3 25
-6.2%
-5.0%
Q2 25
-6.1%
26.1%
Q1 25
1.0%
0.1%
Q4 24
-18.8%
-20.9%
Q3 24
9.5%
25.3%
Q2 24
10.7%
30.7%
Q1 24
9.7%
-7.1%
Capex Intensity
HTLD
HTLD
IMCR
IMCR
Q4 25
33.0%
2.8%
Q3 25
20.2%
0.7%
Q2 25
16.1%
0.4%
Q1 25
10.7%
0.3%
Q4 24
34.3%
4.3%
Q3 24
4.2%
1.0%
Q2 24
3.8%
0.4%
Q1 24
1.7%
0.6%
Cash Conversion
HTLD
HTLD
IMCR
IMCR
Q4 25
Q3 25
Q2 25
Q1 25
0.09×
Q4 24
Q3 24
2.42×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons